VEGFA and neoplasm: The vascular endothelial growth factor (VEGF) highly expressed in M2 TAMs can promote tumor progression and metastasis 162, so the usage of siRNA against VEGF can become a promising approach for improving tumor suppression by interrupting the recruitment of inflammatory M2 TAMs.